Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrauterine Insemination With Letrozole Versus Intrauterine Insemination in Natural Cycle. A Muticenter Randomized Controlled Trial

NCT04169451 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT04169451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04169451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrauterine Insemination With Letrozole Versus Intrauterine Insemination in Natural Cycle. A Muticenter Randomized Controlled Trial
Lead sponsor
Peking University Third Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
September 29, 2022
Completion date
June 30, 2026
Enrollment
982 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intrauterine insemination, unexplained infertility